Cargando…

Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus

Mycobacterium abscessus is associated with antibiotic resistance and poor treatment outcomes. We described within-patient changes in M. abscessus resistance to clarithromycin and amikacin. Patients with amikacin exposure and a >50-month interval between M. abscessus isolates were identified. Anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daniel-Wayman, Shelby, Shallom, Shamira, Azeem, Nabila, Olivier, Kenneth N., Zelazny, Adrian M., Prevots, D. Rebecca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536947/ https://www.ncbi.nlm.nih.gov/pubmed/31149626 http://dx.doi.org/10.1183/23120541.00154-2018

Ejemplares similares

Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China
por: Zhang, Zhijian, et al.
Publicado: (2022)

Evolution of Mycobacterium abscessus in the human lung: Cumulative mutations and genomic rearrangement of porin genes in patient isolates
por: Shallom, Shamira J., et al.
Publicado: (2023)

Impact on Macrolide Resistance of Genetic Diversity of Mycobacterium abscessus Species
por: Jong, Bor-En, et al.
Publicado: (2022)

A novel DNA chromatography method to discriminate Mycobacterium abscessus subspecies and macrolide susceptibility
por: Yoshida, Mitsunori, et al.
Publicado: (2021)

Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates
por: Kim, Su-Young, et al.
Publicado: (2021)

Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
por: Palucci, Ivana, et al.
Publicado: (2023)

High-level Relatedness among Mycobacterium abscessus subsp. massiliense Strains from Widely Separated Outbreaks
por: Tettelin, Hervé, et al.
Publicado: (2014)

MAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection
por: Guo, Qi, et al.
Publicado: (2021)

Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin
por: Yang, Jeng-How, et al.
Publicado: (2022)

Rapid Detection of Clarithromycin and Amikacin Resistance in Mycobacterium abscessus Complex by High-Resolution Melting Curve Analysis
por: Li, Haoran, et al.
Publicado: (2022)

Amikacin Liposomal Inhalation Suspension in the Treatment of Mycobacterium abscessus Lung Infection: A French Observational Experience
por: Chiron, Raphael, et al.
Publicado: (2022)

Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar
por: Christianson, Sara, et al.
Publicado: (2016)

Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay
por: Portell-Buj, Elena, et al.
Publicado: (2021)

Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand
por: Ananta, Pimjai, et al.
Publicado: (2018)

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study
por: Henriette Zweijpfenning, Sanne Maria, et al.
Publicado: (2022)

Genomic characterization of sporadic isolates of the dominant clone of Mycobacterium abscessus subspecies massiliense
por: Davidson, Rebecca M., et al.
Publicado: (2021)

In Vitro Antimicrobial Susceptibility of Mycobacterium abscessus in Korea
por: Park, Sunghoon, et al.
Publicado: (2008)

Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the whiB7 Gene
por: Pryjma, Mark, et al.
Publicado: (2017)

In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics
por: Shen, Yaojie, et al.
Publicado: (2018)

Antibacterial activity of high-dose nitric oxide against pulmonary Mycobacterium abscessus disease
por: Bogdanovski, Kristijan, et al.
Publicado: (2020)

In vitro and intracellular activities of novel thiopeptide derivatives against macrolide-susceptible and macrolide-resistant Mycobacterium avium complex
por: Park, Jiyun, et al.
Publicado: (2023)

Canaliculitis por Mycobacterium abscessus subsp. abscessus
por: Tello, María Nieves Carmona, et al.
Publicado: (2021)

Unusual prophages in Mycobacterium abscessus genomes and strain variations in phage susceptibilities
por: Amarh, Elizabeth D., et al.
Publicado: (2023)

Mixed Infection of Mycobacterium abscessus subsp. abscessus and Mycobacterium tuberculosis in the Lung
por: Sohn, Sungmin, et al.
Publicado: (2017)

Mycobacteriophage-drived diversification of Mycobacterium abscessus
por: Sassi, Mohamed, et al.
Publicado: (2014)

1418. Pharmacokinetics (PK) and Toxicity of Intravenous Amikacin (AMK) Dosed Three Times a Week (TIW) for Treatment of Disseminated Mycobacterium abscessus Infection in Children
por: Tran, M Tuan, et al.
Publicado: (2018)

Relationship between Antibiotic Susceptibility and Genotype in Mycobacterium abscessus Clinical Isolates
por: Li, Bing, et al.
Publicado: (2017)

Effect of Coptis chinensis on Biofilm Formation and Antibiotic Susceptibility in Mycobacterium abscessus
por: Tseng, Cheng-Yin, et al.
Publicado: (2020)

Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to Mycobacterium abscessus Infections
por: Schnitker, Fabian, et al.
Publicado: (2023)

Norovirus, Astrovirus, and Sapovirus in a Tertiary Care Research Hospital
por: Daniel-Wayman, Shelby, et al.
Publicado: (2017)

Mycobacterium abscessus – to treat or not to treat
por: Pang, Yong-Kek, et al.
Publicado: (2013)

Treatment of Mycobacterium abscessus Infection
por: Novosad, Shannon A., et al.
Publicado: (2016)

Mycobacterium abscessus: It’s Complex
por: Abdelaal, Hazem F. M., et al.
Publicado: (2022)

Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series
por: Namkoong, Ho, et al.
Publicado: (2016)

Population heterogeneity in Mycobacterium smegmatis and Mycobacterium abscessus
por: Born, Sarah E. M., et al.
Publicado: (2023)

Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance
por: Dedrick, Rebekah M., et al.
Publicado: (2021)

Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus
por: Negatu, Dereje A., et al.
Publicado: (2023)

Single Cell Analysis of Drug Susceptibility of Mycobacterium abscessus during Macrophage Infection
por: Brzostek, Joanna, et al.
Publicado: (2020)

Impact of Susceptibility to Injectable Antibiotics on the Treatment Outcomes of Mycobacterium abscessus Pulmonary Disease
por: Park, Youngmok, et al.
Publicado: (2021)

Treating Primary Arthroprosthesis Infection Caused by Mycobacterium abscessus subsp. abscessus
por: Pace, Valerio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ik94iuiihucs7q5s6qmuo8o4in